CMMB - CIK 0001534248
The table below shows Chemomab Therapeutics Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.45M | $5.04M | $10.38M | $20.77M | $10.74M | $9.88M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.61M |
| $13.46M |
| $27.70M |
| $33.78M |
| $48.73M |
| $54.83M |
| Property, plant & equipment | $217.00K | $276.00K | $338.00K | $352.00K | $380.00K | $355.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $11.13M | $14.54M | $28.85M | $35.01M | $50.22M | $56.38M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $1.43M | $4.31M | $6.83M | $7.00M | $5.48M | $4.39M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.43M | $4.56M | $6.86M | $7.06M | $5.59M | $4.54M |
| Retained earnings | -$108.00M | -$96.18M | -$80.54M | -$72.57M | -$55.55M | -$47.47M |
| Total equity | $9.70M | $9.98M | $21.99M | $27.95M | $44.62M | $51.84M |